Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

12.940
-0.080-0.61%
Volume:2.11M
Turnover:27.33M
Market Cap:22.80B
PE:-47.93
High:13.150
Open:12.980
Low:12.860
Close:13.020
52wk High:20.620
52wk Low:5.130
Shares:1.76B
HK Float Shares:1.49B
Volume Ratio:0.36
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.270
ROE:-3.55%
ROA:-2.10%
PB:3.06
PE(LYR):-47.93
PS:14.27

Loading ...

How Investors May Respond To InnoCare Pharma (SEHK:9969) Advancing Novel B7-H3 ADC and Next-Gen TRK Inhibitor

Simply Wall St.
·
Nov 02, 2025

InnoCare Pharma Insider Lowered Holding By 89% During Last Year

Simply Wall St.
·
Nov 01, 2025

HK Short Interest Data as of October 31

Stock News
·
Oct 31, 2025

InnoCare Pharma (9969) Schedules Board Meeting for Third-Quarter 2025 Results

Bulletin Express
·
Oct 31, 2025

Some InnoCare Pharma Limited (HKG:9969) Shareholders Look For Exit As Shares Take 26% Pounding

Simply Wall St.
·
Oct 15, 2025

INNOCARE (09969) Repurchases 800,000 Shares for HK$11.768 Million on October 10

Stock News
·
Oct 10, 2025

Asian Growth Companies With High Insider Ownership In October 2025

Simply Wall St.
·
Oct 02, 2025

INNOCARE Surges Over 7% in Early Trading as Tafasitamab Receives First Prescriptions Nationwide

Deep News
·
Sep 30, 2025

GTHT Assigns "Buy" Rating to INNOCARE with HKD 26.7 Target Price

Stock News
·
Sep 23, 2025

Morgan Stanley: Enhanced Market Recognition of Biotech Stocks Drives Outperformance, Bullish on AKESO (09926) and Others

Stock News
·
Sep 23, 2025

InnoCare Pharma Limited (HKG:9969) Shares Could Be 33% Below Their Intrinsic Value Estimate

Simply Wall St.
·
Sep 20, 2025

Hong Kong Stock Alert | INNOCARE (09969) Surges Over 16% on Heavy Volume in Afternoon Trading Following Singapore Approval of Orelabrutinib for Marginal Zone Lymphoma Treatment

Stock News
·
Sep 12, 2025

BUZZ-Hansoh leads slide in HK-listed biotech shares on report of US curbs

Reuters
·
Sep 11, 2025

Hong Kong Stock Alert | INNOCARE (09969) Surges Over 4% as Core Products Drive Growth in H1, Accelerating Multiple Phase III Autoimmune Registration Clinical Trials

Stock News
·
Sep 03, 2025

Hong Kong Stock Movement | Innovative Drug Concept Stocks See Expanding Declines as Trump Announces Swift Pharmaceutical Tariffs, Morgan Stanley Expects Low Likelihood of BD Taxation

Stock News
·
Aug 26, 2025

InnoCare's Loss Narrows in H1; Shares Down 9%

MT Newswires Live
·
Aug 20, 2025

InnoCare to Buy Remaining Stake in Life Sciences Subsidiary for 476 Million Yuan; Shares Down 9%

MT Newswires Live
·
Aug 20, 2025

InnoCare Pharma Narrows H1 Attributable Loss to 30.1 Million Yuan as Revenue Surges 74% to 731.4 Million Yuan

MT Newswires Live
·
Aug 19, 2025

INNOCARE Releases Interim Report with H1 Net Loss of 30.09 Million Yuan

Deep News
·
Aug 19, 2025

INNOCARE (09969) Reports Interim Results with Adjusted Loss of RMB 15.504 Million, Narrowing 93.62% Year-on-Year

Stock News
·
Aug 19, 2025